Compare
RadNet, Inc. vs Natera, Inc. vs Fortrea Holdings Inc. vs Guardant Health, Inc.
| Latest fiscal year | RadNet, Inc. RDNT | Natera, Inc. NTRA | Fortrea Holdings Inc. FTRE | Guardant Health, Inc. GH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $2.04B | $2.31B | $2.72B | $982.02M |
| Revenue growth (YoY) | +11.5% | +35.9% | +1.0% | +32.9% |
| Gross margin | n/a | n/a | n/a | 64.5% (computed) |
| Operating margin | 3.0% | -13.4% | -32.0% | -44.5% |
| Net margin | -0.9% | -9.0% | -36.2% | -42.4% |
| Net income | -$18.65M | -$208.16M | -$986.20M | -$416.28M |
| EPS (Diluted) | -$0.25 | -$1.52 | -$10.81 | -$3.32 |
| Operating cash flow | $298.82M | $215.30M | $113.50M | -$184.76M |
| Free cash flow | n/a | $109.11M | $88.30M | -$233.07M |
| Cash & equivalents | $767.22M | n/a | $174.60M | $378.20M |
| Total assets | $3.76B | $2.40B | $2.72B | $2.01B |
| Total liabilities | $2.40B | $685.93M | $2.15B | $2.11B |
| Shareholders' equity | $1.36B | $1.71B | $563.50M | -$99.31M |
| Return on year-end equity | -1.4% | -12.2% | -175.0% | n/a |
| Shares outstanding | 74.04M | 139.69M | 93.10M | 130.64M |
Revenue, most recent five fiscal years
| Fiscal year | RadNet, Inc. | Natera, Inc. | Fortrea Holdings Inc. | Guardant Health, Inc. |
|---|---|---|---|---|
| Latest | $2.04B Ended 2025-12-31 | $2.31B Ended 2025-12-31 | $2.72B Ended 2025-12-31 | $982.02M Ended 2025-12-31 |
| 1 year earlier | $1.83B Ended 2024-12-31 | $1.70B Ended 2024-12-31 | $2.70B Ended 2024-12-31 | $739.02M Ended 2024-12-31 |
| 2 years earlier | $1.62B Ended 2023-12-31 | $1.08B Ended 2023-12-31 | $2.84B Ended 2023-12-31 | $563.95M Ended 2023-12-31 |
| 3 years earlier | $1.43B Ended 2022-12-31 | $820.22M Ended 2022-12-31 | $2.84B Ended 2022-12-31 | $449.54M Ended 2022-12-31 |
| 4 years earlier | $1.32B Ended 2021-12-31 | $625.49M Ended 2021-12-31 | $3.06B Ended 2021-12-31 | $373.65M Ended 2021-12-31 |